Bougie or Stylet In Patients Undergoing Intubation Emergently (BOUGIE) (BOUGIE)

March 18, 2021 updated by: Jonathan Casey, Vanderbilt University Medical Center

Bougie or Stylet In Patients Undergoing Intubation Emergently (BOUGIE): a Randomized, Multi-center Trial

Complications are common during tracheal intubations performed outside of the operating room. Successful intubation on the first attempt has been associated with a lower rate of procedural complications, but the proportion of critically ill patients intubated on the first attempt during tracheal intubations outside of the operating room is less than 90%. The bougie, a thin semi-rigid tube that can be placed into the trachea, allowing a Seldinger-like technique of intubating a patient's airway, has been traditionally reserved for difficult or failed airways. However, a recent single center trial of adult patients intubated in an emergency department demonstrated that use of the bougie on the first attempt improved intubation success, compared to use of a traditional stylet.

Theinvestigators propose a multi-center randomized trial to compare first-attempt bougie use versus endotracheal tube with stylet use for tracheal intubation of critically ill adults in the ED and ICU.

Study Overview

Status

Completed

Detailed Description

The BOUGIE trial is a prospective, parallel group, pragmatic, randomized trial comparing the effect of bougie use versus endotracheal tube with stylet use on the incidence of successful intubation on the first attempt among adults undergoing urgent or emergent tracheal intubation.

Patients admitted to the study units who are deemed by their clinical team to require intubation and fulfill inclusion criteria without meeting exclusion criteria will be randomized 1:1 to use of a bougie or use of an endotracheal tube and stylet on the first attempt at intubation. All other decisions regarding airway management, including the choice to use a bougie or endotracheal tube and stylet on subsequent attempts, will remain at the discretion of the treating provider.

The trial will enroll 1,106 patients. Conduct of the trial will be overseen by a Data Safety Monitoring Board. An interim analysis will be performed after the enrollment of 553 patients. The analysis of the trial will be conducted in accordance with a pre-specified statistical analysis plan, which will be submitted for publication or made publicly available prior to the conclusion of enrollment.

The primary outcome is successful intubation on the first attempt

The secondary outcome is severe hypoxemia (lowest arterial oxygen saturation between induction and two minutes following intubation of less than 80%)

Study Type

Interventional

Enrollment (Actual)

1106

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35233
        • University of Alabama at Birmingham
    • Colorado
      • Denver, Colorado, United States, 80045
        • University of Colorado
      • Denver, Colorado, United States, 80204
        • Denver Health and Hospital Authority
    • Iowa
      • Iowa City, Iowa, United States, 52242
        • University of Iowa Hospital
    • Louisiana
      • New Orleans, Louisiana, United States, 70112
        • Ochsner Medical Center | Ochsner Health System
      • New Orleans, Louisiana, United States, 70112
        • Louisiana State University School of Medicine
    • New York
      • Bronx, New York, United States, 10451
        • Lincoln Medical Center
    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University Medical Center
      • Lexington, North Carolina, United States, 27292
        • Wake Forest Baptist Health
    • Tennessee
      • Nashville, Tennessee, United States, 37209
        • Vanderbilt University Medical Center
    • Washington
      • Seattle, Washington, United States, 98104
        • Harborview Medical Center, University of Washington

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patient is located in a participating unit of an adult hospital
  2. Planned procedure is tracheal intubation with sedative administration (or tracheal intubation without sedative administration during cardiac arrest)
  3. Planned operator is a clinician expected to routinely perform tracheal intubation in the participating unit
  4. Planned laryngoscopy device is a non-hyperangulated laryngoscope blade

Exclusion Criteria:

  1. Patient is pregnant
  2. Patient is a prisoner
  3. Urgency of intubation precludes safe performance of study procedures
  4. Operator feels an approach to intubation other than use of a bougie or use of an endotracheal tube with stylet would be best for the care of the patient
  5. Operator feels use of a bougie is required or contraindicated for the care of the patient
  6. Operator feels use of an endotracheal tube with stylet is required or contraindicated for the care of the patient

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: BOUGIE

For patients randomized to use of a bougie, the operator will use a bougie on the first attempt at intubation. If successful, an assistant will load an endotracheal tube over the bougie, and the operator (without removing the laryngoscope from the mouth) will guide the tube through the vocal cords to the desired depth in the trachea.

If the bougie is not successfully placed in the trachea or the endotracheal tube cannot be successfully advanced over the bougie on the first attempt at intubation, the operator may use any approach during subsequent attempts at tracheal intubation.

disposable tracheal tube introducer of approximately 70 cm in length
ACTIVE_COMPARATOR: Endotracheal Tube with Stylet

For patients randomized to use of an endotracheal tube with stylet, the operator will use an endotracheal tube containing a removeable, malleable stylet, on the first attempt at intubation.

Manipulation of the shape/curve of the endotracheal tube with stylet is at the discretion of the operator, however a "straight-to-cuff" shape and a bend angle of 25° to 35° is encouraged. The stylet will be left in place until the tube is advanced to the trachea.

If the endotracheal tube with stylet is not successfully placed in the trachea on the first attempt at intubation, the operator may use any approach during subsequent attempts at tracheal intubation.

endotracheal tube preloaded with a removable, malleable stylet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of intubations with successful intubation on the first attempt
Time Frame: from induction to 2 minutes following tracheal intubation
The primary outcome is successful intubation on the first attempt. Successful intubation on the first attempt is defined as placement of an endotracheal tube in the trachea (confirmed by standard means including capnography) following: (1) a single insertion of a laryngoscope blade into the mouth and (2) EITHER a single insertion of a bougie into the mouth followed by a single insertion of an endotracheal tube into the mouth OR a single insertion of an endotracheal tube with stylet into the mouth.
from induction to 2 minutes following tracheal intubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of intubations with severe hypoxemia
Time Frame: from induction to 2 minutes following tracheal intubation
Defined as an oxygen saturation less than 80% during the time interval from induction to two minutes after completion of the intubation procedure
from induction to 2 minutes following tracheal intubation

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cormack-Lehane grade of glottic view on first attempt
Time Frame: from induction to 2 minutes following tracheal intubation
Grade 1: Full view of glottis Grade 2: Partial view of glottis Grade 3: Only epiglottis seen (none of glottis) Grade 4: Neither glottis nor epiglottis seen
from induction to 2 minutes following tracheal intubation
Number of laryngoscopy attempts
Time Frame: from induction to 2 minutes following tracheal intubation
from induction to 2 minutes following tracheal intubation
Number of attempts at passing bougie
Time Frame: from induction to 2 minutes following tracheal intubation
from induction to 2 minutes following tracheal intubation
Number of attempts at passing endotracheal tube
Time Frame: from induction to 2 minutes following tracheal intubation
from induction to 2 minutes following tracheal intubation
Duration of intubation
Time Frame: from the first of induction or initiation of laryngoscopy to 2 minutes following tracheal intubation
The start of the procedure will be defined as either the time of first sedative administration or the time of initiation of laryngoscopy among patients who do not receive a sedative. The end of the procedure will be defined as the time of the final placement of an endotracheal tube within the trachea.
from the first of induction or initiation of laryngoscopy to 2 minutes following tracheal intubation
Use of video laryngoscope screen
Time Frame: from induction to 2 minutes following tracheal intubation
Operator report of use of video laryngoscope screen on first attempt among intubations where the operator used a video laryngoscope
from induction to 2 minutes following tracheal intubation
Number of intubations with esophageal intubation
Time Frame: from induction to 2 minutes following tracheal intubation
Operator report of whether or not an esophageal intubation occurred
from induction to 2 minutes following tracheal intubation
Number of intubations with operator-reported aspiration
Time Frame: from induction to 2 minutes following tracheal intubation
Operator report of whether or not an an aspiration event occurred
from induction to 2 minutes following tracheal intubation
Number of intubations with airway trauma
Time Frame: from induction to 2 minutes following tracheal intubation
Operator report of whether or not airway trauma occurred
from induction to 2 minutes following tracheal intubation
Number of intubations with cardiac arrest within 1 hour following intubation
Time Frame: within 1 hour following intubation
within 1 hour following intubation
Number of intubations with peri-intubation cardiovascular collapse
Time Frame: within 1 hour following intubation

Defined as any of:

  1. New systolic blood pressure < 65 mmHg between induction and 2 minutes following intubation
  2. New or increased vasopressor between induction and 2 minutes following intubation
  3. Cardiac arrest within 1 hour following intubation
  4. Death within 1 hour following intubation
within 1 hour following intubation
The number of ICU-free days, for each intubation, in the first 28 days
Time Frame: 28 days
28 days
The number of ventilator free days, for each intubation, in the first 28 days
Time Frame: 28 days
28 days
The number of patients who experience all-cause in-hospital mortality
Time Frame: 28 days
28 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jonathan D Casey, MD, Vanderbilt University Medical Center
  • Principal Investigator: Brian E Driver, MD, Hennepin County Medical Center, Minneapolis
  • Principal Investigator: Matthew E Prekker, MD, Hennepin County Medical Center, Minneapolis

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 29, 2019

Primary Completion (ACTUAL)

February 14, 2021

Study Completion (ACTUAL)

March 13, 2021

Study Registration Dates

First Submitted

April 19, 2019

First Submitted That Met QC Criteria

April 23, 2019

First Posted (ACTUAL)

April 26, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 22, 2021

Last Update Submitted That Met QC Criteria

March 18, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 182123

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Failure

Clinical Trials on Bougie

Subscribe